Neurology

Washington University School of Medicine’s $616 million research facility will bring together experts in a wide variety of neurological conditions who are working toward new treatments and technologies.

Biogen’s new Alzheimer's drug, Aduhelm, is controversial — but it’s still in demand. Dr. Joy Snider, a Washington University neurologist, explains the issues involving the first Alzheimer's drug to receive FDA approval.

Composer Tobias Picker has five operas to his credit, with commissions from the LA Opera and the Metropolitan Opera, among others, and serious acclaim.…

For years, doctors have used an expensive brain scan to detect symptoms of Alzheimer's disease. But researchers at Washington University have found that a…

When Washington University neurosurgeons Albert Kim and Eric Leuthardt aren’t teaching, researching or performing surgery, they often think of creative…

Washington University researchers are testing a wearable biosensor that can detect potential motor impairments early, while kids are still young enough to…